EUVIMEDEUVIMED entdecken
Open Access

T2-FLAIR Mismatch: An Imaging Biomarker for Children’s MYB/MYBL1 –Altered Diffuse Astrocytoma or Angiocentric Glioma

E A van Maren iD, J W Dankbaar iD, P Wesseling, S Plasschaert iD, A Muhlebner iD, E W Hoving, P A Robe, T J Snijders iD, R Hoogendijk iD, M E G Kranendonk, M H Lequin iD

American Journal of Neuroradiology · 2024

DOI: 10.3174/ajnr.a8203 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Neuroradiology, 2024. Verfasst von E A van Maren und 10 weiteren Autor:innen. Beteiligte Einrichtung: From the Department of Radiology and Nuclear Medicine (E.A.v.M., J.W.D., M.H.L.), University Medical Center Utrecht, Utrecht, the Netherlands. Hauptthemen laut MEDLINE: Astrocytoma, Brain Neoplasms, Glioma, Magnetic Resonance Imaging. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND AND PURPOSE: T2-FLAIR mismatch is a highly specific imaging biomarker of IDH-mutant diffuse astrocytoma in adults. It has however also been described in MYB/MYBL1-altered low grade tumors. Our aim was to assess the diagnostic power of the T2-FLAIR mismatch in IDH-mutant astrocytoma and MYB/MYBL1-altered low-grade tumors in children and correlate this mismatch with histology. MATERIALS AND METHODS: We evaluated MR imaging examinations of all pediatric patients, performed at the Princess Máxima Center for Pediatric Oncology and the University Medical Center Utrecht between January 2012 and January 2023, with the histomolecular diagnosis of IDH-mutant astrocytoma, diffuse astrocytoma MYB/MYBL1-altered, or angiocentric glioma, and the presence of T2-FLAIR mismatch was assessed. Histologically, the presence of microcysts in the tumor (a phenomenon suggested to be correlated with T2-FLAIR mismatch in IDH-mutant astrocytomas in adults) was evaluated. RESULTS: Nineteen pediatric patients were diagnosed with either IDH-mutant astrocytoma (n = 8) or MYB/MYBL1-altered tumor (n = 11: diffuse astrocytoma, MYB- or MYBL1-altered n = 8; or angiocentric glioma n = 3). T2-FLAIR mismatch was present in 11 patients, 3 (38%) in the IDH-mutant group and 8 (73%) in the MYB/MYBL1 group. No correlation was found between T2-FLAIR mismatch and the presence of microcysts or an enlarged intercellular space in either IDH-mutant astrocytoma (P = .38 and P = .56, respectively) or MYB/MYBL1-altered tumors (P = .36 and P = .90, respectively). CONCLUSIONS: In our pediatric population, T2-FLAIR mismatch was more often found in MYB/MYBL1-altered tumors than in IDH-mutant astrocytomas. In contrast to what has been reported for IDH-mutant astrocytomas in adults, no correlation was found with microcystic changes in the tumor tissue. This finding challenges the hypothesis that such microcystic changes and/or enlarged intercellular spaces in the tissue of these tumors are an important part of explaining the occurrence of the T2-FLAIR mismatch.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AstrocytomaBrain NeoplasmsGliomaMagnetic Resonance ImagingProto-Oncogene Proteins c-mybHumansChildMaleFemaleAdolescentChild, PreschoolTrans-ActivatorsBiomarkers, TumorIsocitrate DehydrogenaseInfantMutationRetrospective StudiesProto-Oncogene Proteins

Substanzen

MYBL1 protein, humanProto-Oncogene Proteins c-mybTrans-ActivatorsMYB protein, humanBiomarkers, TumorIsocitrate DehydrogenaseProto-Oncogene Proteins

Autor:innen und Institutionen

  • From the Department of Radiology and Nuclear Medicine (E.A.v.M., J.W.D., M.H.L.), University Medical Center Utrecht, Utrecht, the Netherlands.
  • From the Department of Radiology and Nuclear Medicine (E.A.v.M., J.W.D., M.H.L.), University Medical Center Utrecht, Utrecht, the Netherlands j.w.dankbaar@umcutrecht.nl.
  • Princess Máxima Center for Pediatric Oncology (P.W., S.P., E.W.H., R.H., M.E.G.K., M.H.L.), Utrecht, the Netherlands.
  • Department of Pathology (P.W.), Amsterdam University Medical Centers/VU Medical Center, Amsterdam, the Netherlands.
  • Department of Pathology (A.M.), University Medical Center Utrecht, Utrecht, the Netherlands.
  • Department of Neurosurgery (E.W.H., P.A.R.), University Medical Center Utrecht, Utrecht, the Netherlands.

ORCID-Profile: E A van Maren, J W Dankbaar, S Plasschaert, A Muhlebner, T J Snijders, R Hoogendijk, M H Lequin

Zitieren

APA

van Maren, E. A., Dankbaar, J. W., Wesseling, P., Plasschaert, S., Muhlebner, A., Hoving, E. W., Robe, P. A., Snijders, T. J., Hoogendijk, R., Kranendonk, M. E. G., & Lequin, M. H. (2024). T2-FLAIR Mismatch: An Imaging Biomarker for Children’s MYB/MYBL1 –Altered Diffuse Astrocytoma or Angiocentric Glioma. American Journal of Neuroradiology. https://doi.org/10.3174/ajnr.a8203

Vancouver

van Maren EA, Dankbaar JW, Wesseling P, Plasschaert S, Muhlebner A, Hoving EW, et al. T2-FLAIR Mismatch: An Imaging Biomarker for Children’s MYB/MYBL1 –Altered Diffuse Astrocytoma or Angiocentric Glioma. American Journal of Neuroradiology. 2024. doi:10.3174/ajnr.a8203

BibTeX
@article{vanMaren2024,
  author = {van Maren, E A and Dankbaar, J W and Wesseling, P and Plasschaert, S and Muhlebner, A and Hoving, E W and Robe, P A and Snijders, T J and Hoogendijk, R and Kranendonk, M E G and Lequin, M H},
  title = {T2-FLAIR Mismatch: An Imaging Biomarker for Children’s MYB/MYBL1 –Altered Diffuse Astrocytoma or Angiocentric Glioma},
  journal = {American Journal of Neuroradiology},
  year = {2024},
  doi = {10.3174/ajnr.a8203}
}
Kostenlos starten →